Using your textbooks, draw up a classification of the drugs that are used as antidepressants.
SSRI’s |
SNRI’s |
TCA’s |
5-HT antagonist |
Tetracyclic and Unicyclic |
MOAI |
NARI |
Fluoxetine Sertraline Citalopram Paroxetine Escitalopram |
Venlafaxine Duloxetine Desvenlafaxine |
Tertiary amine:
Secondary amine
|
Trazodone Nefazodone Vortioxetine
|
Bupropion Mirtazapine Amoxapine Maprotiline
|
Phenelzine Isocarboxazid Tranylcypromine Selegiline Moclobemide
|
Reboxetine |
All of these drugs promote monoamine activity by increasing NA and serotonin levels at the central synapse, by either re-uptake inhibition, degradation inhibition or the blockage of the presynaptic alpha 2 receptor.
The onset is very slow and can take up to 6-8 weeks for effects to be seen due to the action that of the anti-depressants that still needs to be altered in the brain.
Efficacy
TAD: needs to be titrated to the minimum effective dose whereas SSRI’s can be started on the full dose. All these drugs does however take 6-8 weeks for effects to be seen.
Side effects
TAD: sedation, tremors, insomnia, disturbed vision, dry mouth, urinary retention, confusion, orthostatic hypotension, dysrhythmias convulsions, weight gain and sexual dysfunction.
SSRI: Insomnia, tremors, GIT disturbances, headache, ↓ libido, sexual dysfunction, anxiety (acute), EPS, withdrawal syndrome. ↓ appetite, non-sedating, acute increases 5-HT synaptic activity = acute anxiety, later 5-HT reduces again.
Safety
TAD: Not safe in overdose but it is commonly the drug used for suicide. It causes lethal ventricular arrythmias and fibrillation and seizures.
SSRI: it is very safe with regards to overdose and this drug is better tolerable.
It blocks the action of alpha 2, 5-HT2A, 5-HT2c and 5-HT3 receptors. It also blocks histamine 1 and alpha 1 and causes the indirect stimulation of 5-HT1A
Blocks both 5-HT - and NA re-uptake, more potent for 5- HT than for NA. Moderately selective blockade of SERT and NET..
Antagonist: 5-HT2C
Agonist: Melatonergic R’s – MT1 & MT2. and NA release.